ST-segment elevation myocardial infarction (STEMI)

Find all the latest content on STEMI published on this website.

Treating STEMI brings into play a series of clinical and organizational protocols in constant evolution. Today, patients presenting with STEMI are best treated by early reperfusion strategies of which primary PCI is the preferred method. Keep up-to-date on the role of adjunctive pharmacotherapy, advances in imaging techniques and the use of invasive imaging and functional assessment. Tools, devices and techniques as well as complications, such as the different types of vascular access or bleeding risk can be found here as well…

Filtered By
STEMI

538 results

Extensive anterior STEMI - Treatment strategies from SCAI A to E

22 May 2025 – From EuroPCR 2025

Explore comprehensive treatment strategies for extensive anterior STEMI, focusing on risk stratification across the SCAI shock stages A to E. Learn to adapt mechanical circulatory support appropriately and understand principles guiding device selection and utilization in hemodynamic instability.

Extensive anterior STEMI - Treatment strategies from SCAI A to E

Role of coronary physiology in acute coronary syndrome patients

22 May 2025 – From EuroPCR 2025

Examine the role of coronary physiology in acute coronary syndrome patients, including plaque characteristics related to ACS risk, prognostic value of AngioIMR in STEMI, functional significance of lumen and plaque features, diagnostic accuracy of quantitative flow ratio, and the impact of adenosine administration routes on FFR...

Role of coronary physiology in acute coronary syndrome patients

What an interventional cardiologist should know about anti-thrombotics

22 May 2025 – From EuroPCR 2025

This session provides comprehensive knowledge on anti-thrombotic management for interventional cardiologists, emphasizing effective inhibition during acute STEMI, latest evidence implementation for high bleeding risk patients, and customization of dual antiplatelet therapy in patients with high thrombotic and low bleeding risks through clinical cases and evidence-based recommendations.

What an interventional cardiologist should know about anti-thrombotics

Spotlight on major Late-Breaking Trials presented at EuroPCR 2025

21 May 2025

These trials were selected because of their design, results, and potential to impact practice: Discover the key findings of the 4D-ACS and FAITAVI randomised clinical trials and a meta-analysis of PROTECTED TAVR and BHF PROTECT TAVI.

Selection of top Late-breaking Trials presented at #EuroPCR

Treatment and prognostic stratification of ACS patients with cardiogenic shock

21 May 2025 – From EuroPCR 2025

This session focuses on treatment and prognostic stratification in ACS patients complicated by cardiogenic shock. Topics include mechanical CPR device performance, SCAI shock grade dynamics, hemorrhagic event predictors, ECMO-related strategies, and evaluation of BCIS conveyance algorithms for out-of-hospital cardiac arrest.

Treatment and prognostic stratification of ACS patients with cardiogenic shock

Challenges in the treatment of patients with left main disease

21 May 2025 – From EuroPCR 2025

Address the challenges in treating patients with left main disease by reviewing bifurcation techniques, intravascular imaging complexities, and intervention dilemmas in renal patients. Cases highlight management of calcified left main disease post-STEMI and nuanced lesion presentations.

Challenges in the treatment of patients with left main disease

Imaging-based strategies for complication management in STEMI

21 May 2025 – From EuroPCR 2025

Discover imaging-based strategies to manage complications during STEMI interventions. This session discusses diagnostic clues such as spasm, stuck devices, and slow flow, and illustrates complex scenarios including extreme stent challenges and application of CTO techniques to STEMI cases for optimized outcomes.

Imaging-based strategies for complication management in STEMI

Challenging STEMI cases: unwanted situations

21 May 2025 – From EuroPCR 2025

Address challenging STEMI cases involving multivessel disease, high thrombus burden, and spontaneous coronary artery dissection. This session provides case-based learning on managing unexpected scenarios, diagnostic approaches, and tailored treatment strategies in complex STEMI presentations.

Challenging STEMI cases: unwanted situations

Complications in STEMI : dissections and more

21 May 2025 – From EuroPCR 2025

Address complications encountered in STEMI interventions such as dissections and coronary perforations. Learn from case presentations highlighting procedural challenges, management of delayed perforations, and balancing procedural perfection with practical outcomes.

Complications in STEMI : dissections and more

Primary PCI for STEMI – Optimising outcomes

21 May 2025 – From EuroPCR 2025

Optimize primary PCI outcomes for STEMI patients by integrating state-of-the-art techniques and coronary physiology insights. The session includes case discussions highlighting treatment strategies and key learnings to enhance clinical practice.

Primary PCI for STEMI – Optimising outcomes